[go: up one dir, main page]

AR117579A1 - SPECIFIC ANTIBODIES FOR GUCY2C AND ITS USES - Google Patents

SPECIFIC ANTIBODIES FOR GUCY2C AND ITS USES

Info

Publication number
AR117579A1
AR117579A1 ARP190101350A ARP190101350A AR117579A1 AR 117579 A1 AR117579 A1 AR 117579A1 AR P190101350 A ARP190101350 A AR P190101350A AR P190101350 A ARP190101350 A AR P190101350A AR 117579 A1 AR117579 A1 AR 117579A1
Authority
AR
Argentina
Prior art keywords
gucy2c
specific antibodies
antibodies
cancer
treatment
Prior art date
Application number
ARP190101350A
Other languages
Spanish (es)
Inventor
Edward Roland Lavallie
Lidia Mosyak
Adam Reid Root
Divya Mathur
Madan Katragadda
Gurkan Guntas
Chew Shun Chang
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR117579A1 publication Critical patent/AR117579A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Anticuerpos que se fijan de manera específica a GUCY2c y usos de estos en el tratamiento del cáncer. Además proporciona anticuerpos biespecíficos que comprenden dichos anticuerpos y usos de estos en el tratamiento del cáncer.Antibodies that specifically bind to GUCY2c and uses of these in the treatment of cancer. It also provides bispecific antibodies comprising said antibodies and uses of these in the treatment of cancer.

ARP190101350A 2018-05-23 2019-05-21 SPECIFIC ANTIBODIES FOR GUCY2C AND ITS USES AR117579A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862675617P 2018-05-23 2018-05-23

Publications (1)

Publication Number Publication Date
AR117579A1 true AR117579A1 (en) 2021-08-18

Family

ID=77568237

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190101350A AR117579A1 (en) 2018-05-23 2019-05-21 SPECIFIC ANTIBODIES FOR GUCY2C AND ITS USES

Country Status (1)

Country Link
AR (1) AR117579A1 (en)

Similar Documents

Publication Publication Date Title
PE20210488A1 (en) ANTIBODIES SPECIFIC TO GUCY2C AND ITS USES
EA202091540A1 (en) ANTIBODIES TO LILRB2
UY37779A (en) ANTIBODY MOLECULES THAT JOIN CD73 AND USES OF THE SAME
CL2019001874A1 (en) Context-permissive isoform-specific tgfß1 inhibitors and their use.
CL2018001512A1 (en) Humanized anti-CD73 antibodies.
PE20210287A1 (en) ANTI-CD25 FOR THE DEPLETION OF SPECIFIC TUMOR CELLS
CO2021006869A2 (en) Humanized antibodies against c-kit
CO2017010618A2 (en) Antibodies against icos
MX2021002970A (en) NKG2D-BINDING PROTEINS, CD16 AND AN ANTIGEN ASSOCIATED WITH A TUMOR.
ECSP17083779A (en) IMMUNORECEPTOR BINDING AGENTS OF T-CELLS WITH GI DOMAINS AND INHIBITION MOTIVES BASED ON IMMUNORECEPTOR TYROSINE (TIGIT) AND USES THEREOF
CO2020013089A2 (en) Antibodies against mica and / or micb and their uses
CL2017000278A1 (en) Bispecific t-cell activating antigen binding molecules
MX381046B (en) ANTI-CSF1R ANTIBODIES AND PD-1/PD-L1 INHIBITORS, AND USES THEREOF FOR THE TREATMENT OF CANCER REFERRAL TO RELATED APPLICATIONS.
CO2017001191A2 (en) Drug conjugates with anti-cdh6 antibodies
BR112016030740A2 (en) bispecific heterodimeric bodies and their uses
TN2017000470A1 (en) Heterodimeric antibodies that bind cd3 and tumor antigens.
BR112019005908A2 (en) use of anti-pd-1 antibody and vegfr inhibitor combination in cancer drug preparation
PE20181013A1 (en) BISPECIFIC ANTIBODY CONSTRUCTS THAT BIND EGFRVIII AND CD3
EA201791554A1 (en) BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20
CL2021000258A1 (en) Anti-btn3a antibodies and their use in the treatment of cancer or infectious disorders.
CL2017002983A1 (en) Combined therapy of an anti-cd-20 antibody with a bcl-2 inhibitor and an mdm2 inhibitor
CL2016001753A1 (en) Humanized monoclonal antibody that specifically binds to netrin-1, pharmaceutical compositions and uses of the antibody for cancer treatment
EA201891299A1 (en) THERAPEUTIC ANTIBODIES TO CD9
MX2020009130A (en) Therapeutic anti-spla2-gib antibodies and the uses thereof.
ES2721935T3 (en) Anti-BAG3 antibodies for therapeutic use

Legal Events

Date Code Title Description
FA Abandonment or withdrawal